Open
Programme
£2000000.00
12 June 2025 at 12:00 am
11 March 2026 at 1:00 pm
97026
Ready to apply?
Apply for this funding opportunity through our online application form
| Description | Deadline/Timeline |
|---|---|
| Application available online | 05 November 2024 |
| Deadlines for outline application submission* | 11 June 2025, 1pm (Wave 1) 11 March 2026, 1pm (Wave 2) |
| Notification of outcome of outline application | July/August 2025 (Wave 1) May 2026 (Wave 2) |
| Deadline for full application submission | 25 September 2025, 1pm (Wave 1) 07 July 2026, 1pm (Wave 2) |
| Notification of outcome of full application | January 2026 (Wave 1) October 2026 (Wave 2) |
| Expected start of Research Awards | 01 April 2026 (Wave 1) 01 January 2027 (Wave 2) |
| Budget | £750k to £2m per Research Award |
| Project Duration | up to 36 months |
* We have decided to design this round of Research Awards (formerly called Research Collaboration Awards) as a rolling call. There will be two deadlines for outline applications: one in June 2025 and the other in March 2026. This will offer two opportunities for researchers to apply. Bidders who are unsuccessful within the Wave 1 outline application process can use Committee feedback and apply again in Wave 2. We hope that this will offer a more flexible approach to obtaining research funding.
How to apply
To apply for this funding opportunity you will need to log in through the NIHR Awards Management System. Click the link below to log-in to the system and start your application.
Because NIHR funding schemes have different aims and review processes, the following are *general, evidence-based predictors shared across most programmes (domestic and global). NIHR
1️⃣ Relevance to NIHR’s Mission and Priorities
NIHR applications are first assessed on relevance to NIHR’s remit: improving patient outcomes, NHS and social care effectiveness, public health impact, or addressing policy priorities. Alignment with programme-specific aims (e.g., public health, clinical efficacy, translational science) is essential. NIHR
✔ Clearly articulate how your research fits the selected NIHR programme’s objectives and addresses health or care needs.
2️⃣ Scientific Quality & Rigor
High-quality research design — including hypothesis clarity, robust methodology and feasibility — is central. Research must address important gaps, be methodologically sound and ethically justified. NIHR
✔ Demonstrate rigorous methodology, justified sample sizes, valid measures, and feasibility within the funding timeline.
3️⃣ Impact and Knowledge Mobilisation
NIHR places high value on impact — not just scientific outputs, but benefits to patients, the NHS, care systems or society. This includes practical pathways to implementation and plans to disseminate results effectively. NIHR
✔ Include knowledge mobilisation strategies (e.g., how findings will influence policy, practice, or public health).
4️⃣ Strength of the Research Team
A credible team with appropriate expertise, track record and clear roles improves confidence in delivery. For large or multidisciplinary programmes, collaboration across institutions (academia + NHS + stakeholders) is often a strength. NIHR
✔ Provide strong CVs, evidence of productivity, and clear role descriptions for all key team members.
5️⃣ Feasibility and Realistic Planning
NIHR reviewers assess whether the project can realistically be completed within the proposed timeframe, resources and regulatory environment (e.g., ethics, governance). NIHR
✔ Present a clear timeline, milestones, risk mitigation and budget justification.
6️⃣ Patient and Public Involvement (PPI)
NIHR particularly values meaningful involvement of patients and the public in research design, conduct and dissemination, particularly for clinical and health services research. Review criteria often assess the quality of PPI input. NIHR
✔ Show active PPI engagement in shaping the research question and design.
7️⃣ Governance and Regulatory Readiness
NIHR requires high standards of research governance, ethical approval, data protection, trial registrations (if applicable) and adherence to regulatory frameworks; omissions can weaken competitiveness. NIHR
✔ Address ethical, regulatory, and governance considerations clearly in your application.
8️⃣ Competitive Two-Stage Processes
Many NIHR schemes (e.g., RfPB) use outline/tracker → full proposal two-stage assessments, with about half of outlines invited to submit full proposals. Rank, clarity and early feedback matter. NIHR
✔ Invest effort especially in the outline stage — succinct, compelling case and clear plans can strongly influence full invites.
📍 Choose the right programme: NIHR has many schemes (HTA, RfPB, HSDR, PHR, EME, PGfAR, fellowships, global health). Read the specific funding brief and criteria carefully. NIHR
📍 Early engagement: Contact NIHR Research Design Services or programme contacts to refine aims and methods.
📍 PPI strategy: Develop strong, documented patient/public involvement early — reviewers often score this explicitly. NIHR
📍 Plan impact: Include pathways to benefit patients, NHS operations, and policy change, not just publication dissemination.
📍 Document feasibility: Regulatory and data management plans reassure reviewers of practical deliverability.
| Predictor | Why It Matters |
|---|---|
| Mission alignment | Ensures fit to programme priorities and remit. NIHR |
| Scientific quality | Foundation of funding decisions. NIHR |
| Impact & mobilisation | NIHR emphasises NHS and societal benefit. NIHR |
| Team strength | Confidence in execution. NIHR |
| Feasibility | Project deliverability within context. NIHR |
| Patient & public involvement | A core NIHR value. NIHR |
| Governance readiness | Mitigates delivery risks. NIHR |
| Outline clarity in two-stage schemes | Key in early screening. |
This will offer two opportunities for researchers to apply. Bidders who are unsuccessful within the Wave 1 outline application process can use Committee feedback and apply again in Wave 2. We hope that this will offer a more flexible approach to obtaining research funding.
Sponsor Institute/Organizations: National Institute for Health and Care Research (NIHR)
Sponsor Type: Corporate/Non-Profit
Address: 201 Bishopsgate, London, EC2M 3AB
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Mar 11, 2026
Jul 07, 2026
$2,680,000
£2000000
Affiliation: National Institute for Health and Care Research (NIHR)
Address: 201 Bishopsgate, London, EC2M 3AB
Website URL: https://www.nihr.ac.uk/funding/nihr-work-and-health-research-awards-round-2/97026#tab-timetable-and-budget
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.